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Yinghua Zou, MD, Beijing, China
Objective: To describe our experience with the treatment of renal artery aneurysms (RAAs) and renal arteriovenous
ﬁstulas (RAVFs) by transcatheter techniques with special consideration given to indications, technical options, and
complications.
Methods: Over the last 7 years (2004-2011), endovascular treatment of nine RAAs and six RAVFs in 15 patients
(11 women; mean [standard deviation] age, 42 [15] years; range, 18-75 years) was retrospectively reviewed. Seven
aneurysms and six arteriovenous ﬁstulas were treated with coil embolization. One aneurysm was treated with the stent
graft, and the other aneurysm was treated with coil embolization combined with stent graft. Electronic medical charts
were reviewed, and demographic, clinical, procedural, and follow-up data were analyzed.
Results: The lesion was asymptomatic in seven patients and symptomatic in eight patients, including ruptures in two
patients. The most common comorbidity and associated risk factor was hypertension (n [ 8). The technical success rate
was 100%. There was no periprocedural mortality or major complications. The only complication was postembolization
syndrome in nine patients. Mean clinical follow-up was 24.7 months, and mean imaging follow-up was 16.3 months.
During the imaging follow-up, partial renal infarcts were detected in six patients, with no evidence of renal insufﬁciency.
No recurrence was observed.
Conclusions: At our institution, endovascular therapy represents the ﬁrst-line treatment of RAAs and RAVFs.
Postembolization syndrome and segmental renal infarcts are common events but were not found to be clinically
signiﬁcant. (J Vasc Surg 2013;57:765-70.)Renal artery aneurysm (RAA) and renal arteriovenous
ﬁstula (RAVF) are rare entities. The RAAs are discovered
in 0.3% to 0.7% of autopsies and up to 1% of renal arterio-
graphic procedures.1 Although the true incidences are
unknown, the historical data estimate that RAVFs are
found in approximately 0.04% of the general population.2
However, the widespread use of noninvasive imaging tools,
such as duplex ultrasonography (DUS), computed tomog-
raphy (CT), and magnetic resonance imaging (MRI), has
led to the diagnosis and treatment of an increasing number
of cases.
Previously, surgery was the standard treatment option
for RAAs and RAVFs. Recently, with evolving of endovas-
cular technique, endovascular treatment has offered a viable
alternative with a high technical success rate and low
procedure-related morbidity and mortality. This retrospec-
tive review describes our experience with the endovascular
treatment of RAAs and RAVFs with special consideration
given to the indications, technical considerations, and
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This retrospective study was approved by the institu-
tional review board. The electronic medical ﬁles were
reviewed to identify patients who underwent endovascular
treatment of RAAs or RAVFs between November 2004
and December 2011. During this period, a total of 372
renal interventions were performed, and 20 patients were
diagnosed with RAA or RAVF in our institution. Endovas-
cular treatment was performed in 15 patients (11 women;
mean [standard deviation] age, 42 [15] years; range, 18-75
years). This included nine RAAs and six RAVFs. The
remaining ﬁve asymptomatic patients with small RAAs
(<1 cm) were left untreated and under close surveillance.
The medical records of the treated patients were reviewed
with regard to demographic data, comorbidities, clinical
presentations, characteristics of RAAs or RAVFs, endovas-
cular techniques, and outcomes. The estimated glomerular
ﬁltration rates were calculated before the procedures and
during the latest follow-up.3
Pre- and postoperative images, consisting of DUS,
computed tomographic angiography (CTA), magnetic
resonance angiography (MRA), digital subtraction angiog-
raphy (DSA), or a combination of these, were reviewed
from stored electronic images.
Technique. Written informed consent was obtained
from all patients. The procedures were performed by inter-
ventional radiologists in the catheterization laboratory, and
a total of six interventionalists were involved in these cases.
Technical success was deﬁned as exclusion of the aneurysm
and cessation of blood ﬂow through the arteriovenous
shunt without evidence of contrast medium extravasation765
JOURNAL OF VASCULAR SURGERY
766 Zhang et al March 2013or hemorrhage. When possible, attempts were made to
preserve the native arterial tree and renal parenchyma.
Vascular access was obtained through the right femoral
artery in all procedures under local anesthesia. Selective
renal angiography was performed via 5F Cobra catheter
(Cook Inc, Bloomington, Ind) or Sos catheter (AngioDy-
namic, Latham, NY), in anteroposterior and oblique views,
to clearly demonstrate the anatomy of RAAs and RAVFs.
For patients who did not present with bleeding, a single
bolus of 3000 units of heparin was given intravenously
before the embolization. Coil embolizations were applied
in 13 patients (seven RAAs and six RAVFs). The procedures
were performed by placing the coils through the 5F cathe-
ters or microcatheter (Progreat; Terumo, Tokyo, Japan) in
the aneurysm sacs or distally at the level of efferent branches
and proximally in the feeding arteries. Either 0.035-inch
(Nester; Cook) or 0.018-inch coils (Tornado or Micro-
Nester; Cook) or detachable coils (GDC; Boston Scientiﬁc,
Natick, Mass) were used in embolization.
In three patients with RAVFs, angiography demon-
strated large aneurysmatic arteriovenous communications
between the segmental renal artery branches and the veins.
Due to the possibility of coil migrations and severe compli-
cations, we introduced the 5.5F Fogarty balloon catheters
(Edwards Lifesciences, Irvine, Calif) through a 7F long
sheath (Cook) coaxially. The Fogarty balloons were posi-
tioned at the proximal feeding arteries of the AVFs and
inﬂated to temporarily occlude blood ﬂow. Under balloon
protection, coils were introduced and deployed in the
feeding arteries via the Fogarty catheters. After some coils
were placed into the feeding arteries, the balloon was
slightly deﬂated and contrast was gently injected through
the catheter to test the stability of the coils. If no move-
ment of the coils was observed as well as the stagnating
blood in the feeding arteries, the balloon could be deﬂated
completely. If displacement was detected after balloon
deﬂation, the coils were considered unstable. The proce-
dures were repeated to obtain dense and stable packing
(Fig 1). The mean occlusion time in these three procedures
was approximately 25 minutes.
Stent graft alone was applied in one patient with an
aneurysm in the left inferior segmental renal artery branch
due to favorable anatomy. After renal angiography, a 6F
guiding catheter (RDC; Boston Scientiﬁc) was advanced
to the ostium of the left main renal artery. A bolus of
5000 units of heparin was administered intravenously,
and the pipeline was ﬂushed with heparinized saline
(5000 units in 500 mL of normal saline) to maintain an
activated clotting time between 300 and 350 seconds
throughout the procedure. The lesion was crossed with
a 0.014-inch guidewire (Pilot 50; Abbott, Santa Clara,
Calif). A 5-mm  16-mm covered stent (Jostent; Jomed,
Helsingborg, Sweden) was introduced over the guidewire
and deployed across the lesion. A ﬁnal arteriogram showed
excellent graft position, aneurysm exclusion, and no sign of
endoleak. The patient was given aspirin 300 mg and
clopidogrel 300 mg immediately after the stent deploy-
ment, and heparin was discontinued. He was dischargeduneventfully 3 days after the procedure on a regimen of
aspirin 100 mg for life and clopidogrel 75 mg daily for 3
months (Fig 2).
Follow-up and statistical analysis. Medical records,
technical data, and follow-up information were available
for all patients. Pre- and postprocedural images and
angiograms were analyzed by two experienced interven-
tional radiologists, and estimated renal parenchymal loss
(as percentage of total renal parenchyma) was reached by
consensus. Follow-up was performed by clinical examina-
tion and DUS, CTA, MRA, or DSA at 3, 6, and 12 months
after the procedure and annually thereafter.
Discrete data are presented as frequency and perc-
entage. Data for continuous variables are expressed as
mean (standard deviation). More than 20% increase of
serum creatinine value with imaging evidence of renal
infarct was deﬁned as clinically relevant worsening of renal
function.
RESULTS
During the study period, 15 patients underwent endo-
vascular management of RAAs or RAVFs. The lesions were
asymptomatic and discovered incidentally in seven patients;
eight patients (four RAAs, four RAVFs) were symptomatic.
Symptoms included ﬂank pain related to the side where the
lesion was located (n ¼ 3), rupture with gross hematuria
(n ¼ 1), and rupture with hemorrhagic shock (n ¼ 1).
Three patients with RAVFs presented with hypertension,
and each of them had a history of abdominal penetrating
injury 3 to 7 years before they presented with hypertension.
One patient with an RAA who was pregnant and in the
third trimester was admitted to the emergency room for
hemorrhagic shock. She underwent emergency caesarean
section for fetal distress with blood and volume resuscita-
tion, and gave birth to a healthy baby girl. After closure
of the uterus, the pelvis and abdomen were explored, and
a huge retroperitoneal hematoma was found. The patient
was admitted to the intensive care unit. The day after the
operation, the patient again became hemodynamically
unstable, and an emergency angiogram showed a ruptured
aneurysm located at the bifurcation of right main renal
artery. She underwent coil embolization of aneurysm sac,
and ﬁnal angiography showed no residual ﬁlling of the
sac and no contrast medium extravasation. Her vital signs
stabilized, and she was discharged home 7 days after the
procedure uneventfully.
Comorbidities and associated risk factors included
systemic hypertension (n ¼ 8), hyperlipemia (n ¼ 4), ante-
cedent history of abdominal penetrating injury (n ¼ 3),
coronary heart disease (n ¼ 2), and pregnancy (n ¼ 1).
Anatomic distribution of aneurysms treated included right
main renal artery bifurcation (n ¼ 5), right segmental
branch artery bifurcation (n ¼ 2), and left segmental
branch (n ¼ 2). All aneurysms were saccular aneurysms
(9/9). Mean aneurysm size was 2.7 cm (range, 2.0-
4.0 cm). The RAVFs involved right segmental branches
in three patients and left segmental branches in three
patients. Four patients had aneurysmatic ﬁstulas.
Fig 1. A young man (patient no. 12), who previously had abdominal penetrating trauma, presented with hypertension.
A, Volume-rendering computed tomographic (CT) image showing giant right renal arteriovenous ﬁstula (RAVF) with
a dilated feeding artery (arrow) and early ﬁlling of the renal vein (arrowhead). B, Selective arteriogram of outﬂow vessel
of the aneurysm with balloon occlusion via the microcatheter showing the aneurysmal ﬁstula and early ﬁlling of the
inferior vena cava (IVC). C, Arteriogram after coil embolization of the outﬂow vessel with balloon occlusion showing
the aneurysmal ﬁstula without ﬁlling of the IVC.D, Embolization of the feeding artery performed under the protection
of an inﬂated balloon. There is persistent contrast medium in the aneurysm secondary to lack of blood ﬂow. E, Final
arteriogram demonstrating absence of RAVF ﬁlling with other branches preserved and improved nephrogram. A partial
renal infarct is noted. F, Follow-up CT angiographic image 12 months after the procedure demonstrating no reper-
fusion of the RAVF, and the other branches are patent.
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procedural morbidity was not observed. The patient with
ruptured RAA and hemorrhagic shock required admittance
to the intensive care unit and blood transfusions. Three
patients with RAVFs who had presented with hypertension
before the procedure had clinical cure of their high blood
pressure. None of the ﬁve patients with RAAs and hyper-
tension showed improvement or worsening of their hyper-
tension during follow-up. In one patient with gross
hematuria, the bleeding disappeared after embolization.
The patients with ﬂank pain presented with total or partial
improvement of their symptoms.
Complications. Evaluation of major and minor
complications was performed according to Society of
Interventional Radiology criteria.4 There were no major
complications. Postprocedural imaging was available for
all patients and consisted of MRI/MRA (n ¼ 2), CT
(n ¼ 10), DUS (n ¼ 2), and DSA (n ¼ 1). Mean clinical
follow-up was 24.7 months (range, 4-53 months), and
mean imaging follow-up was 16.3 months (range, 3-35months). Renal infarcts induced by embolization rep-
resented <10% of total renal parenchyma in two patients
and <30% in three patients as determined by the neph-
rogram on ﬁnal angiography and follow-up imaging.
Postembolization syndrome (PES), deﬁned as a combina-
tion of fever, leukocytosis, abdominal pain, nausea, and
vomiting, was noted in nine patients. Mean duration of
PES was 2 days (range, 1-3 d). The PES was treated with
intravenous antibiotics, analgesia, and rest. Access site
complications did not occur. No patient demonstrated
gross evidence of aneurysm sac growth or endoleak during
follow-up (Table).
DISCUSSION
The RAAs and RAVFs are rare, with a wide range of
etiologies. Most RAAs are likely to be medial degenerative,
with loss or fragmentation of elastic ﬁbers and reduced
smooth muscle resulting in weakness of the elastic lamina.5
Other causes of RAAs are arteriosclerosis, ﬁbromuscular
dysplasia, and connective tissue disorders. The majority
Fig 2. A 38-year-old woman (patient no. 11) presented with left
ﬂank discomfort, and a wide-necked renal artery aneurysm (RAA)
was found. A, Left renal arteriogram demonstrating a saccular
aneurysm located in the left segmental branch with the wide neck
(arrow). B, Final arteriogram demonstrating the aneurysm was
excluded from the circulation without evidence of an endoleak
after placement of the stent graft (arrow).
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almost invariably are found at the renal artery bifurcation.6
The RAVFs may be congenital or acquired. Traumatic
AVFs are the most common lesions, accounting for
>70% of all RAVFs.7 These lesions may occur after
nephrectomy, renal artery angioplasty, blunt or penetrating
trauma, nephrostomy, or percutaneous renal biopsy.
Most RAAs are asymptomatic and found incidentally.
Although rare, the most feared risk of RAA is rupture,with a reported incidence of 5% to 10% and a mortality
rate as high as 80%.8 Pregnant women have a higher rate
of rupture, especially during the third trimester, with resul-
tant 70% maternal mortality and approximately 100% fetal
mortality.9 Other presentations of RAA include hyperten-
sion, hematuria, and ﬂank pain. Clinical manifestations of
RAVFs depend on their size and location. Although they
often are asymptomatic, hypertension, hematuria, high
output cardiac failure, and even rupture may occur.
The rare occurrence of RAAs and RAVFs has created
a debate regarding the threshold for treatment. Indications
for treatment should take into account patient age, gender,
blood pressure, comorbidity, renal function, aneurysm size,
and complexity of treatment. The current consensus for
treating RAAs includes (1) RAAs $1.0 cm, with difﬁcult-
to-control hypertension; (2) RAAs >2.0 cm or docu-
mented enlarging aneurysm; (3) symptomatic RAAs; (4)
RAAs in pregnant women or in women of child-bearing
age; and (5) RAAs associated with functionally signiﬁcant
renal artery stenosis or renal malperfusion.8 All of the
RAVFs that were detected were treated.
The RAAs and RAVFs can be treated with surgical or
endovascular approaches. Surgical options consist of aneur-
ysmectomy, ex vivo repair then auto transplantation, liga-
tion of inﬂow and outﬂow vessels, or nephrectomy in
rare cases. Endovascular treatment has rapidly evolved,
and several techniques are available for RAA and RAVF
therapy. However, the treatment option remains an
individual-based decision depending on vascular anatomy,
available technology, and operator experience.
Because most RAAs are saccular, simple coil ﬁlling of
the sac often is sufﬁcient to treat narrow neck aneurysm.
However, this can be expensive and time consuming
depending on sac volume. This technique should be used
with caution when used for a wide neck aneurysm because
coil migration and continued sac perfusion are possible. For
these conditions, stent-assisted coil embolization is appro-
priate.10 A bare mental stent is ﬁrst placed across the
neck of the aneurysm to act as a scaffold, followed by inser-
tion of coils into the sac through the struts of the stent. The
other stent-assisted coiling procedure involves looping
a catheter in the aneurysm sac, followed by deployment
of the stent across the aneurysm neck, “trapping” the cath-
eter in the sac. Additionally, in circumstances of acute
aneurysm rupture, coil occlusion of the parent artery or
even of the main renal artery may be the most expeditious
treatment option despite signiﬁcant impact on renal
function.
Stent grafts provide another means of excluding the
aneurysm from systemic blood ﬂow. Stent grafts usually
are reserved for main renal arteries with diameter $6 mm
due to the risk of thrombosis of smaller arteries.11 The
rigidity and large proﬁle of the delivery system preclude it
passing through the tortuous arteries. A renal guiding cath-
eter and a working wire with good trackability and shape-
able tip are needed to obtain a stable carrier system and to
keep ﬂushing the pipeline. For planning the treatment
strategy, three-dimensional rotational angiography can
Table. Angiographic ﬁndings, technical data, and outcomes of treatment
Patient
No.
Type of
lesion Location
Type of
treatment Complication
Serum
creatinine
before/after,
mmol/L
Estimated
glomerular
ﬁltration rate
before/after,
mL/min/1.73 m2
Follow-up
clinical/imaging,
months
1 RAA Right mRA
bifurcation
Coil embolization PES, partial renal
infarction (10%)
95/83 77/90 53/35
2 RAA Left segmental
branch artery
Coil embolization PES, partial renal
infarction (10%)
60/72 148/116 42/28
3 RAVF Left segmental
branch artery
Balloon-assisted coil
embolization
PES, partial renal
infarction (30%)
112/121 94/84 37/24
4 RAA Right mRA
bifurcation
Coil embolization PES 66/73 109/96 46/21
5 RAA Right mRA
bifurcation
Coil embolization PES 81/78 90/93 32/25
6 RAVF Left segmental
branch artery
Coil embolization PES, partial renal
infarction (30%)
67/61 109/120 32/19
7 RAA Right mRA
bifurcation
Coil embolization No 34/44 228/168 27/18
8 RAA Right segmental
branch artery
bifurcation
Coil embolization No 44/51 188/157 24/12
9 RAVF Right segmental
branch artery
Coil embolization PES 62/65 115/108 20/18
10 RAVF Left segmental
branch artery
Coil embolization No 164/167 54/52 10/6
11 RAA Left segmental
branch artery
Stent grafting No 67/57 112/134 16/12
12 RAVF Right segmental
branch artery
Balloon-assisted coil
embolization
PES, partial renal
infarction (10%)
75/87 140/117 14/12
13 RAVF Right segmental
branch artery
Balloon-assisted coil
embolization
No 93/90 67/69 7/6
14 RAA Right segmental
branch artery
bifurcation
Coil embolization No 67/66 103/105 6/6
15 RAA Right mRA
bifurcation
Coil embolization þ
stent grafting
PES, partial renal
infarction (30%)
57/61 128/118 4/3
mRA, Main renal artery; PES, postembolization syndrome; RAA, renal artery aneurysm; RAVF, renal arteriovenous ﬁstula.
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sions of the aneurysm and tortuosity of the afferent and
efferent vessels so that we can choose a suitable stent graft.
Otherwise, postdilating the stent graft can improve wall
apposition and prevent endoleak.
Endovascular embolization is now considered the ﬁrst-
line treatment of RAVFs with the beneﬁt of decreased
morbidity. However, it also involves risk of several distinct
complications. The main risk is pulmonary embolism result-
ing frommigration of embolic agents. The risk is particularly
great in large, high-ﬂow ﬁstulas. This has led to the
development of techniques that allow for protection of the
venous system. Gralino and Bricker12 reported a case of
staged endovascular occlusion of giant RAVF with micro-
coils and silk suture threads using ﬂow control with balloon
deﬂation and inﬂation in the venous outﬂow. Mori et al13
reported a case of high-ﬂow RAVF embolized using an
interlocking detachable coil to function as a coil anchor
with simultaneous balloon inﬂation to decrease arterial
ﬂow and allow stabilization of the coil. Resnick and
Chiang14 used a constrained Wallstent (Boston Scientiﬁc,
Natick, Mass) that was deployed within the AVF to preventcoil migration. The “stop-ﬂow” technique reported by
Mansueto et al15 requires simultaneous catheterization of
the feeding artery and draining vein. An occluding balloon
is inﬂated in the draining vein to prevent migration of
embolic material from the feeding artery into the venous
system. Using this technique, the investigators reported
safe release of acrylic glue with no evidence of migration
into the pulmonary bed.
In three cases we reported, due to the high ﬂow and
large diameter of the RAVFs we used inﬂated balloon cath-
eters positioned in the feeding arteries beyond their normal
arterial branches to occlude the bloodstream. The coils
then could be delivered through the lumen of the balloon
catheter into the stagnant distal lumen of the feeding artery
until the total occlusion of the RAVFs.
The most common complications of endovascular
treatment of RAA and RAVF include renal artery dissec-
tion, PES, loss of renal function, and coil migration. Renal
function can be adversely affected by use of nephrotoxic
iodinated contrast media or by devascularization of
a portion of the renal parenchyma from the embolization.
Superselective embolization, with coaxial catheters and
JOURNAL OF VASCULAR SURGERY
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renal tissue. In our series, radiologic evidence of partial
renal infarct was found in ﬁve patients (33.3%). However,
an adverse effect of the endovascular procedure on renal
function was not observed.
Study limitations. There are limitations to our study.
It is a retrospective study with a small study population,
which precludes meaningful statistical analysis. Our assess-
ment of renal function impairment is limited to evaluation
of serum creatinine, which is an approximate indicator.
Evaluation of the percentage of renal function loss after
embolization using functional imaging such as renal scin-
tigraphy would provide more clarity on this issue. Angiog-
raphy would have been an ideal follow-up method;
however, it is not practical in the vast majority of patients
because the procedure is invasive and expensive. More
patients underwent follow-up with DUS, CT, and MR
because these tests are more feasible. However, radiologic
artifact of the coil may hamper accurate assessment of
aneurysmal sac growth or arteriovenous shunt reﬁlling.
Moreover, the size of the renal infarct was more likely to be
overlooked or underestimated in the three patients who
underwent DUS or DSA follow-up. Due to the retro-
spective nature of our study, we could not compare our
treatment outcomes with surgery. Longer-term follow-up
with larger patient cohorts are necessary to elucidate the
ultimate role of endovascular treatment of RAAs and
RAVFs.
CONCLUSIONS
Endovascular treatment has become the ﬁrst-line treat-
ment of RAAs and RAVFs at our institution because it
offers several advantages over conventional surgery,
including low morbidity and mortality, high technical and
clinical success rates, and excellent early and mid-term
results. Although partial renal infarction was observed in
some patients, no evidence suggested that it would induce
clinically relevant worsening of renal function.
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